| Date Filed | Type | Description |
| 10/02/2023 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 5,797 shares
@ $0 |
|
| 10/02/2023 |
4
| HUNT RONALD (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 3,035 shares
@ $0 |
|
| 10/02/2023 |
4
| Chin Mark (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 3,035 shares
@ $0 |
|
| 09/29/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 07/06/2023 |
4
| Chin Mark (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 18,656 shares
@ $0 |
|
| 07/06/2023 |
4
| HUNT RONALD (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 18,656 shares
@ $0 |
|
| 07/06/2023 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 35,634 shares
@ $0 |
|
| 05/31/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/30/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/16/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/16/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 04/27/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/21/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 04/14/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 04/04/2023 |
4
| Viney Joanne L. (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 21,028 shares
@ $0 |
|
| 04/04/2023 |
4
| Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 34,925 shares
@ $0 |
|
| 04/04/2023 |
4
| HUNT RONALD (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 18,285 shares
@ $0 |
|
| 04/04/2023 |
4
| Colowick Alan (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 16,456 shares
@ $0 |
|
| 04/04/2023 |
4
| Chin Mark (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 18,285 shares
@ $0 |
|
| 03/31/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 03/31/2023 |
SC 13G
| Artal International S.C.A. reports a 6.1% stake in Harpoon Therapeutics, Inc. |
| 03/29/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/27/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/27/2023 |
8-K
| Quarterly results |
| 03/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/06/2023 |
SC 13G/A
| New Leaf Ventures III, L.P. reports a 9.8% stake in Harpoon Therapeutics, Inc. |
| 01/26/2023 |
4
| Lanza Frank J (Principal Fin. & Acctng Ofc.) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 65,000 options to buy
@ $0.89, valued at
$57.9k
|
|
|